It was further demonstrated that the combination of mTORC1 inhibition with ferroptosis induction resulted in substantial tumor regression in mouse models of PI3K-mutated or PTEN-defective cancers (Yi et al., 2020). This evidence concerns the gene PTEN and cancer.